Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 16
2003 11
2004 15
2005 9
2006 4
2007 6
2008 14
2009 13
2010 15
2011 11
2012 12
2013 29
2014 32
2015 24
2016 26
2017 45
2018 33
2019 37
2020 54
2021 52
2022 51
2023 34
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

470 results

Results by year

Filters applied: . Clear all
Page 1
Impact of severe acute kidney injury on short-term mortality in urosepsis.
Fujita N, Momota M, Soma O, Noro D, Mikami J, Miura Y, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C, Hatakeyama S. Fujita N, et al. Among authors: ohyama c. World J Urol. 2024 May 8;42(1):301. doi: 10.1007/s00345-024-05018-w. World J Urol. 2024. PMID: 38717511
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study.
Fujita N, Hatakeyama S, Tabata R, Okita K, Kido K, Hamano I, Tanaka T, Noro D, Tokui N, Suzuki Y, Yoneyama T, Hashimoto Y, Sato S, Ohyama C. Fujita N, et al. Among authors: ohyama c. Prostate Int. 2024 Mar;12(1):46-51. doi: 10.1016/j.prnil.2023.12.002. Epub 2023 Dec 19. Prostate Int. 2024. PMID: 38523900 Free PMC article.
Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study.
Kodama H, Hatakeyama S, Matsuura T, Saito M, Nishida H, Hamaya T, Maita S, Murakami R, Tomita H, Saitoh H, Tsuchiya N, Habuchi T, Obara W, Ohyama C. Kodama H, et al. Among authors: ohyama c. Int Urol Nephrol. 2024 Feb 9. doi: 10.1007/s11255-023-03934-1. Online ahead of print. Int Urol Nephrol. 2024. PMID: 38332424
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.
Mori K, Hatakeyama S, Enokida H, Miyake H, Kikuchi E, Nishiyama H, Ichikawa T, Kamai T, Kaji Y, Kume H, Kondo T, Matsuyama H, Masumori N, Kawauchi A, Takenaka A, Uemura H, Eto M, Nonomura N, Fujii Y, Hinotsu S, Ohyama C. Mori K, et al. Among authors: ohyama c. Int J Urol. 2024 Mar;31(3):194-207. doi: 10.1111/iju.15362. Epub 2023 Dec 19. Int J Urol. 2024. PMID: 38113344 Review.
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.
Koguchi T, Naito S, Hatakeyama S, Numakura K, Muto Y, Kato R, Kojima T, Kawasaki Y, Morozumi K, Kandori S, Kawamura S, Nishiyama H, Ito A, Habuchi T, Obara W, Ohyama C, Tsuchiya N, Kojima Y. Koguchi T, et al. Among authors: ohyama c. Cancer Med. 2023 Nov;12(22):20677-20689. doi: 10.1002/cam4.6591. Epub 2023 Oct 31. Cancer Med. 2023. PMID: 37905674 Free PMC article.
470 results